Yunjie D. Lu
185th Juqian Street
Changzhou, 213003, China
Changzhou, 213003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Engineering Microbial Particles for Next-Generation Biomedical Platforms.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 07, 2026
Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation.
Journal: Small science
Published: September 27, 2025
Genetic and pharmaceutical manipulation of H3K9 methyltransferase Suv39h1 promotes liver regeneration by unleashing HMGB2 transcription.
Journal: Experimental & molecular medicine
Published: June 07, 2025
Clinical perspective and treatment of immune-related colitis after cancer immunotherapy.
Journal: Trends in cancer
Published: May 12, 2025
Hepatitis E virus infection and renal injury in non-immunocompromised host: clinical investigation and rabbit model study.
Journal: Frontiers in cellular and infection microbiology
Published: February 25, 2025
Superellipse Equation Describing the Geometries of Abies alba Tree Rings.
Journal: Plants (Basel, Switzerland)
Published: November 08, 2024
Redox-sensitive epigenetic activation of SUV39H1 contributes to liver ischemia-reperfusion injury.
Journal: Redox biology
Published: September 18, 2024
LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway.
Journal: Journal of cancer research and clinical oncology
Published: February 27, 2024
Prognostic impact of the high-sensitivity modified glasgow prognostic score on patients undergoing radical surgery for hepatocellular carcinoma : Authorship.
Journal: Langenbeck's archives of surgery
Published: February 19, 2024
Ablation of histone methyltransferase Suv39h2 in hepatocytes attenuates NASH in mice.
Journal: Life sciences
Published: January 09, 2024
Gpbar-1/cAMP/PKA signaling mitigates macrophage-mediated acute cholestatic liver injury via antagonizing NLRP3-ASC inflammasome.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 30, 2023
Last Updated: 09/26/2026